Usefulness of home BP determination in treating borderline hypertension

Abstract

Whether home BP [blood pressure] self-determination can be used to assess the effect of treatment in patients with borderline hypertension was examined. Sixteen untreated patients underwent a double-blind trial of propranolol hydrochloride (average dose, 105 mg), clonidine hydrochloride (0.24 mg) and placebo. Home BP readings decreased with both active compounds (-8/-5 with propranolol and -11/-7 with clonidine). During placebo, the readings increased to levels identical to untreated values. Patients with borderline hypertension are consistently capable of detecting small average changes in home BP. Sympatholytic monotherapy can be effectively used to lower the BP in such patients.